Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OrbiMed is a global healthcare-focused investment firm, managing approximately $17–18 billion in assets. It invests in biopharmaceuticals, medical devices, diagnostics, healthcare services, and digital health, with portfolio companies spanning early-stage (preclinical) to late-stage (commercial), and supports innovation across therapeutic modalities and indications. Recent funds provide both equity and non-dilutive credit/royalty solutions to growth-oriented health companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Orbimed Healthcare Fund Management.